GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Equity-to-Asset

Laboratorio Reig Jofre (XMAD:RJF) Equity-to-Asset : 0.62 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Laboratorio Reig Jofre's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €204.4 Mil. Laboratorio Reig Jofre's Total Assets for the quarter that ended in Dec. 2023 was €330.5 Mil. Therefore, Laboratorio Reig Jofre's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.62.

The historical rank and industry rank for Laboratorio Reig Jofre's Equity-to-Asset or its related term are showing as below:

XMAD:RJF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.57   Med: 0.63   Max: 0.7
Current: 0.62

During the past 13 years, the highest Equity to Asset Ratio of Laboratorio Reig Jofre was 0.70. The lowest was 0.57. And the median was 0.63.

XMAD:RJF's Equity-to-Asset is ranked better than
56.03% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs XMAD:RJF: 0.62

Laboratorio Reig Jofre Equity-to-Asset Historical Data

The historical data trend for Laboratorio Reig Jofre's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Equity-to-Asset Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 0.58 0.58 0.61 0.62

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.61 0.59 0.60 0.62

Competitive Comparison of Laboratorio Reig Jofre's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Equity-to-Asset falls into.



Laboratorio Reig Jofre Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Laboratorio Reig Jofre's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=204.351/330.548
=0.62

Laboratorio Reig Jofre's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=204.351/330.548
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Reig Jofre  (XMAD:RJF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Laboratorio Reig Jofre Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.